• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

FDA approves Dysport for cosmetic, therapeutic uses

Article

International report ? The Food and Drug Administration (FDA) approved the Biologics License Application for Dysport (botulinum toxin type A, Medicis, Ipsen) for the treatment of both cervical dystonia in adults and to temporarily improve the appearance of moderate-to-severe glabellar lines in adults younger than 65, Globe Newswire reports.

International report

- The Food and Drug Administration (FDA) approved the Biologics License Application for Dysport (botulinum toxin type A, Medicis, Ipsen) for the treatment of cervical dystonia in adults and to temporarily improve the appearance of moderate-to-severe glabellar lines in adults younger than 65, Globe Newswire reports.

Reloxin, which was the proposed name for Ipsen’s U.S. botulinum toxin product indicated for cosmetic use, will now be marketed under the Dysport name. Ipsen will market the toxin for the therapeutic use and Medicis will market Dysport for the aesthetic indication.

Dysport has established a separate name from other marketed botulinum toxin products, abobotulinumtoxinA, according to Globe Newswire.

Related Videos
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Video 2 - "Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management" - 2 KOLs in this video.
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Video 4 - "Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care " - 1 KOL in this panel
Video 3 - "Tailored Treatments for Non-Segmental Vitiligo in a 38-Year-Old Male Patient" - 1 KOL in this panel
© 2024 MJH Life Sciences

All rights reserved.